ClinicalTrials.gg
Drug

Cyproterone Acetate clinical trials

A product of Cyproterone; its studies count on that page too.

studies test it
15
open now
2
in phase 3
8
first study started
1999

Counted the way a researcher would: Cyproterone Acetate with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Cyproterone Acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Cyproterone Acetate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

cyproterone acetate
8

Brand

Androcur® 50 mg
1
Androcur®
1

Studies by the year they started

13 studies that test it; most in 1999 (2); 1 more planned to start later

Studies that test Cyproterone Acetate, by start year
YearStudies
19992
20031
20041
20091
20101
20121
20141
20161
20172
20191
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 3
8
Phase 4
4
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 11

Medical University of Vienna (2) · Eurofarma Laboratorios S.A. (2) · University Hospital, Rouen (1) · University Hospital, Lille (1) · Benha University (1) · NCIC Clinical Trials Group (1) · S.C.B. Medical College and Hospital (1) · Takeda (1)

Often tested with

Tested in the same studies.

Estradiol (3) · Ethinyl Estradiol (3) · Goserelin (2) · Metformin (2) · Testosterone (2) · Lynestrenol (2) · Finasteride (1) · Bicalutamide (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test Cyproterone Acetate, phase 3 first.

Studies

Open first, then newest update. How each study uses Cyproterone Acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Given beside what is tested · 2 — Cyproterone Acetate is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Cyproterone Acetate

Codes

What other systems call Cyproterone Acetate · ClinicalTrials.gg INT008599

  • MeSH (NLM) D017373Cyproterone AcetateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 4KM2BN5JHFCYPROTERONE ACETATEConfirmed FDA, NLM, Wikidata
  • RxNorm 22054Confirmed FDA, Wikidata
  • Wikidata Q426185cyproterone acetateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1059Cyproterone AcetateOne source FDA
  • DrugBank DB04839One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.